<bill session="117" type="h" number="6329" updated="2023-03-08T19:58:54Z">
  <state datetime="2021-12-20">REFERRED</state>
  <status>
    <introduced datetime="2021-12-20"/>
  </status>
  <introduced datetime="2021-12-20"/>
  <titles>
    <title type="display">National Critical Capabilities Defense Act of 2021</title>
    <title type="short" as="introduced">National Critical Capabilities Defense Act of 2021</title>
    <title type="official" as="introduced">To require reviews of United States investment in foreign countries that may threaten national critical capabilities, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="D000216"/>
  <cosponsors>
    <cosponsor bioguide_id="C001055" joined="2022-01-25"/>
    <cosponsor bioguide_id="D000627" joined="2022-07-28"/>
    <cosponsor bioguide_id="F000466" joined="2021-12-20"/>
    <cosponsor bioguide_id="P000096" joined="2021-12-20"/>
    <cosponsor bioguide_id="S001145" joined="2022-01-11"/>
    <cosponsor bioguide_id="S000929" joined="2021-12-20"/>
    <cosponsor bioguide_id="S001201" joined="2022-01-25"/>
  </cosponsors>
  <actions>
    <action datetime="2021-12-20">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-12-20" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="s" number="1854" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Advisory bodies"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Corporate finance and management"/>
    <term name="Disaster relief and insurance"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Emergency planning and evacuation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Foreign and international corporations"/>
    <term name="Industrial policy and productivity"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Manufacturing"/>
    <term name="Public contracts and procurement"/>
    <term name="Trade agreements and negotiations"/>
    <term name="U.S. and foreign investments"/>
  </subjects>
  <amendments/>
  <summary date="2022-04-11T16:42:04Z" status="Introduced in House">National Critical Capabilities Defense Act of 2021

This bill establishes the Committee on National Critical Capabilities to review certain transactions by U.S. businesses, including those transactions that could result in an unacceptable risk to national critical capabilities. Further, the bill authorizes the President to suspend or prohibit transactions that pose an unacceptable risk to national critical capabilities.</summary>
</bill>
